TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep39692.pdf
Reference36 articles.
1. Jemal, A. et al. Global cancer statistics. CA. Cancer J. Clin. 61, 69–90, doi: 10.3322/caac.20107 (2011).
2. Wao, H., Mhaskar, R., Kumar, A., Miladinovic, B. & Djulbegovic, B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Systematic reviews 2, 10, doi: 10.1186/2046-4053-2-10 (2013).
3. Reymond, A. et al. The tripartite motif family identifies cell compartments. Embo j 20, 2140–2151, doi: 10.1093/emboj/20.9.2140 (2001).
4. Tarantul, V. Z. et al. Differential gene expression in B-cell non-Hodgkin’s lymphoma of SIV-infected monkey. AIDS Res. Hum. Retroviruses 16, 173–179, doi: 10.1089/088922200309511 (2000).
5. Tarantul, V. et al. Detection of abundantly transcribed genes and gene translocation in human immunodeficiency virus-associated non-Hodgkin’s lymphoma. Neoplasia 3, 132–142, doi: 10.1038/sj/neo/7900137 (2001).
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway;Carcinogenesis;2024-01-24
2. TRIM14 and TRIM29 as potential tumor markers for breast cancer diagnosis;Journal of Breast Disease;2023-12-01
3. Higher cytotoxic activities of CD8+ T cells and natural killer cells from peripheral blood of early diagnosed lung cancer patients;BMC Immunology;2023-08-14
4. Tripartite motif‑containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice;Molecular Medicine Reports;2023-07-27
5. Examining the Expression and Correlation of TRIP13 and ANGPT1 in Small Cell Lung Cancer: A Professional Exploration with an Analogy to Football Players;REV INT MED CIENC AC;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3